Tirzepatide carries a boxed warning about thyroid C-cell tumors in rodents and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
The drug, called orforglipron, differs from Lilly's injectable drug, tirzepatide
For additional information or questions about your treatment plan, visit your Alan Health Portal
In Diabetic Patients Excess insulin dose Skipping or delaying meals Intense exercise Alcohol intake Sulfonylureas (e.g., glibenclamide) 2
Customs & Import Duties Import duties, taxes, and customs fees may be charged by the destination country and are the responsibility of the customer unless otherwise stated
If the individual is a good candidate for one of these medications, they may choose to write a prescription for treatment